Entrectinib for the treatment of metastatic NSCLC: safety and efficacy

MLA

Andrea Sartore-Bianchi, et al. “Entrectinib for the Treatment of Metastatic NSCLC: Safety and Efficacy.” Expert Review of Anticancer Therapy, vol. 20, no. 5, Apr. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....959610ea0a5c7006bf42b2d81490ff55&authtype=sso&custid=ns315887.

APA

Andrea Sartore-Bianchi, Federica Tosi, Salvatore Siena, Elio Gregory Pizzutilo, Giulio Cerea, & Giovanna Marrapese. (2020). Entrectinib for the treatment of metastatic NSCLC: safety and efficacy. Expert Review of Anticancer Therapy, 20(5).

Chicago

Andrea Sartore-Bianchi, Federica Tosi, Salvatore Siena, Elio Gregory Pizzutilo, Giulio Cerea, and Giovanna Marrapese. 2020. “Entrectinib for the Treatment of Metastatic NSCLC: Safety and Efficacy.” Expert Review of Anticancer Therapy 20 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....959610ea0a5c7006bf42b2d81490ff55&authtype=sso&custid=ns315887.